The study compares two treatment methods for enhancing function and decreasing pain in adhesive capsulitis of shoulder

EFFECTIVENESS OF ULTRASOUND GUIDED CRYOABLATION OF SUPRASCAPULAR NERVE IN COMPARISON WITH STEROID AND LOCAL ANAESTHETIC BLOCK FOLLOWED BY MANIPULATION FOR REDUCTION OF PAIN AND FUNCTIONAL DISABILITY IN PATIENT WITH ADHESIVE CAPSULITIS OF THE SHOULDER: A RANDOMISED CONTROLLED TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/062152

Enrollment

Registered

2024-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: Ultrasound guided cryoablation of suprascapular nerves: Cryoablation of the Suprascapular Nerve The patient will be kept sitting position with the affected shoulder in full adduction an

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group 40-60 years 2. Diagnosed case of stage II and stage III adhesive capsulitis based on clinical staging 3. Patients who are willing to comply with the study and follow-up assessments

Exclusion criteria

Exclusion criteria: 1. Any recent febrile or infectious disease 2. Patients with osteoporosis 3. Patients with a history of fracture around shoulder joint or dislocations of shoulder joint 4. Malignancy 5. Autoimmune and haematological disorders 6. Impaired cognition 7. Pregnancy

Design outcomes

Primary

Measure	Time frame
Shoulder pain and disability measured by SPADI and VAS Timepoint: At the end of 1st week, 4th week, 12th week and 24th week	—

Secondary

Measure	Time frame
Functional outcome measured by ROM of shoulderTimepoint: At the end of 1st week, 4th week, 12th week and 24th week	—

Countries

India

Contacts

Public ContactLongjam Nilachandra Singh

Regional Institute of Medical Sciences, Imphal

drnilalong@gmail.com7005018045

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026